Print

APL 400-003RX101

GENEVAX-HIV (APL 400-003), A Candidate DNA Vaccine: A Pilot Study of GENEVAX-HIV Given by Intramuscular or Intradermal Administration in HIV Seronegative Volunteers

Trial Details:

I Completed
Walter Reed Army Institute of Research (WRAIR)
APL 400-003 GENEVAX-HIV env,rev
APL 400-003 GENEVAX-HIV DNA
USA 16
http://clinicaltrials.gov/ct2/show/NCT00002350?term=APL+400-003&rank=2